Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPAPRES: Thoracic Epidural vs Intravenous Analgesia in Lung Cancer Surgery
NCT03643757Completed
- Sponsor
- Yedikule Training and Research Hospital
- Start
- Aug 2015
- Primary completion
- Aug 2017
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by Yedikule Training and Research Hospital. Primary endpoints: Postoperative Forced Expiratory Volume in 1 second alteration at 3 days and Postoperative Forced Vital Capacity alteration at 3 days. Started Aug 2015; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03643757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03643757.